PCR
News on qPCR, digital PCR, amplification, point-of-care testing platforms in genetics, genomics, and molecular diagnostics.
CellCarta, Biofidelity Partner to Offer Lung Cancer Assay for Clinical Trials
CellCarta will validate Biofidelity's Aspyre Lung assay in its European and US labs and will hold nonexclusive rights to use it in global clinical trials.
The firm expects Sherlock's chlamydia and gonorrhea self-test to contribute to its growth in 2026, pending FDA clearance.
AstraZeneca to Use Tracer Biotechnologies Cancer Monitoring Tech for Clinical Trials
Tracer has developed a proprietary platform for tumor-informed circulating-tumor DNA detection using digital PCR.
Genomadix, Mayo Clinic Partner on CYP2C19 Testing for Remote Care For Stroke Patients
The partnership is intended to help expand adoption of the company's rapid PCR system in sites that treat stroke patients, including through telemedicine platforms.
Canhelp Genomics Partners With Mirxes Singapore to Offer Tumor Origin Identification Testing
The firms will make the Canhelp-Origin tumor identification test available for patients with cancers of unknown origin in some Southeast Asian countries.